PulseAugur / Brief
EN
LIVE 01:00:54

Brief

last 24h
[2/2] 221 sources

Multi-source AI news clustered, deduplicated, and scored 0–100 across authority, cluster strength, headline signal, and time decay.

  1. RESEARCH · 36氪 (36Kr) 中文(ZH) ·

    Hanyu Pharmaceutical: Signs Sales Cooperation Framework Agreement for Peptide APIs, with Planned Sales Amount Not Less Than 327 Million Yuan

    Hanyu Pharmaceutical has entered into a framework agreement for the sale of peptide APIs with a partner, aiming for a minimum sales value of 327 million yuan. This agreement, signed on May 18th, is intended to expand the company's international business and accelerate the commercialization of its GLP-1 APIs. The projected sales amount represents a significant 33.84% of the company's most recent audited operating revenue. AI

    IMPACT This agreement could signal increased demand for GLP-1 APIs, potentially impacting the broader pharmaceutical and biotech sectors.

  2. MEME · 36氪 (36Kr) 中文(ZH) ·

    Kaidy Shares: Robot-related products are still in the development stage and cannot generate revenue in the short term

    KaiDi Co. announced that its robot-related products are still in the development phase and will not generate revenue in the short term. The company's stock experienced significant price fluctuations, prompting this clarification. Separately, Hanyu Pharmaceutical signed a framework agreement for peptide raw material sales amounting to at least 327 million yuan, and the news also mentioned global free access to ChatGPT Plus and other unrelated financial news. AI